These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6121002)

  • 21. Significant differences in the degradation of pro-leu-gly-nH2 by human serum and that of other species (38484).
    Walter R; Neidle A; Marks N
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):98-103. PubMed ID: 1168915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [3H]9-desglycinamide,8-arginine vasopressin: metabolism and in-vivo fate.
    Verhoef J; van den Wildenberg HM; van Nispen JW
    J Endocrinol; 1986 Sep; 110(3):557-62. PubMed ID: 3760747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific binding of photoaffinity-labeling peptidomimetics of Pro-Leu-Gly-NH2 to the dopamine D2L receptor: evidence for the allosteric modulation of the dopamine receptor.
    Mann A; Verma V; Basu D; Skoblenick KJ; Beyaert MG; Fisher A; Thomas N; Johnson RL; Mishra RK
    Eur J Pharmacol; 2010 Sep; 641(2-3):96-101. PubMed ID: 20639138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformation and activity of +H2-Pro-Leu-Gly-NH2 and its analogues modified at the leucyl residue.
    Kim YJ; Han SJ; Kim SC; Kang YK
    Int J Pept Protein Res; 1995 Nov; 46(5):381-90. PubMed ID: 8567182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteolysis of Pro-Gly-Pro-Leu in the hippocampus, cerebellum, and cerebral cortex in rats after intravenous injection.
    Shevchenko KV; V'yunova TV; Andreeva LA; Nagaev IY; Shevchenko VP; Myasoedov NF
    Bull Exp Biol Med; 2014 Nov; 158(1):37-41. PubMed ID: 25403393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uptake and metabolism of [3H]-Leu-enkephalin following either its intraperitoneal or subcutaneous administration to mice.
    Janak PH; Schulteis G; Martinez JL
    Peptides; 1992; 13(3):551-5. PubMed ID: 1523167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo fate of a behaviorally active ACTH 4-9 analog in rats after systemic administration.
    Verhoef J; Witter A
    Pharmacol Biochem Behav; 1976 May; 4(5):583-90. PubMed ID: 181766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone.
    Martins JM; Kastin AJ; Banks WA
    Neuroendocrinology; 1996 Apr; 63(4):338-48. PubMed ID: 8739889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition of metabolically labeled recombinant soluble CD4 (sT4) in male Sprague-Dawley rats following intravenous and subcutaneous administration.
    Davis CB; Boyle KE; Urbanski JJ; Paradysz RT; Fong KL
    Drug Metab Dispos; 1992; 20(5):695-705. PubMed ID: 1358574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioautographic localization of radioactivity in rat brain after intraventricular or intracarotid injection of 3H-L-prolyl-L-leucyl glycinamide.
    Pelletier G; Labrie F; Kastin AJ; Coy D; Schally AV
    Pharmacol Biochem Behav; 1975; 3(4):675-9. PubMed ID: 242014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptides readily penetrate the blood-brain barrier: uptake of peptides by synaptosomes is passive.
    Greenberg R; Whalley CE; Jourdikian F; Mendelson IS; Walter R; Nikolics K; Coy DH; Schally AV; Kastin AJ
    Pharmacol Biochem Behav; 1976; 5(Suppl 1):151-8. PubMed ID: 13414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and evaluation of a PLG tripeptidomimetic based on a pyridine scaffold.
    Saitton S; Del Tredici AL; Mohell N; Vollinga RC; Boström D; Kihlberg J; Luthman K
    J Med Chem; 2004 Dec; 47(26):6595-602. PubMed ID: 15588094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bicyclic thiazolidine lactam peptidomimetics of the dopamine receptor modulating peptide Pro-Leu-Gly-NH2.
    Subasinghe NL; Bontems RJ; McIntee E; Mishra RK; Johnson RL
    J Med Chem; 1993 Aug; 36(16):2356-61. PubMed ID: 8103113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of tritium label in the neonate rat brain following intracisternal or subcutaneous administration of [3H]6-OHDA. An autoradiographic study.
    Sievers H; Sievers J; Baumgarten HG; König N; Schlossberger HG
    Brain Res; 1983 Sep; 275(1):23-45. PubMed ID: 6414647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carrier-mediated transport of labeled oxytocin from brain to blood.
    Durham DA; Banks WA; Kastin AJ
    Neuroendocrinology; 1991 May; 53(5):447-52. PubMed ID: 1678495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Degradation of melanotropin inhibiting factor by brain.
    Hui KS; Cheng KP; Wong KH; Salschutz M; Lajtha A
    J Neurochem; 1980 Aug; 35(2):471-8. PubMed ID: 6108995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A glial-neuronal-glial communication system in the mammalian central nervous system.
    Berkley KJ; Contos N
    Brain Res; 1987 Jun; 414(1):49-67. PubMed ID: 2441801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution profile of 2,5-dimethoxy-4-bromoamphetamine (DOB) in rats after oral and subcutaneous doses.
    Beránková K; Szkutová M; Balíková M
    Forensic Sci Int; 2007 Aug; 170(2-3):94-9. PubMed ID: 17629428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-dopa potentiating analogs of Pro-Leu-Gly-NH2 with oral efficacy.
    Albrecht HP; Hofman HP; Klebe G; Kreiskott H
    Boll Chim Farm; 1991 Feb; 130(2):55-9. PubMed ID: 1678611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.